ZK 6032924
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZK 6032924, covering 2014-04-02 to 2015-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers [Phase 1]